ArticleTropical animal health and production2026
First report of 'Candidatus Anaplasma camelii' and high molecular prevalence of Anaplasma marginale in dromedary camels (Camelus dromedarius) from Somalia.
Article in Tropical animal health and production, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anaplasmosis, a zoonotic disease caused by Anaplasma species, threatens Somalia’s dromedary population, crucial to the nation’s economy and society. This study examines its occurrence in dromedaries from two Somali bioclimatic regions using molecular and serological methods. A total of 155 blood and serum samples from dromedaries in Benadir and Lower Shabelle were analyzed. Serum samples underwent rMSP5-based ELISA for anti-Anaplasma marginale IgG antibodies. DNA was extracted from dromedary blood samples followed by molecular screening included nested PCR for the 16S rRNA gene of Anaplasma spp. and qPCR for the msp1β gene of A. marginale. Positive samples underwent further PCR and sequencing targeting five additional genes for definitive species confirmation and phylogenetic analysis. Of 155 dromedaries tested, 30 (19.4%) were seropositive for Anaplasma marginale by iELISA, and 117 (75.5%) were qPCR-positive for the msp1β gene. Notably, 97 animals that were seronegative by iELISA tested positive by qPCR, and the overall agreement between the two tests was substantial (κ = 0.62). Among 22 qPCR-positive samples, semi-nested PCR (snPCR) targeting the msp1α gene detected six positives (27.3%). The molecular prevalence of A. marginale was significantly higher in Benadir (84.6%) compared to Lower Shabelle (56.9%). A significant association was also observed between A. marginale infection and tick infestation, with infested dromedary camels showing lower odds of being positive (OR = 0.4). Initial nPCR screening identified Anaplasma spp. positive in 45 (29%) of animals, with 23 (14.8%) showing co-infections between A. marginale and Anaplasma spp. Further analysis of 25 selected nPCR-positive samples revealed positivity for ITS 17 (68%), groEL 12 (48%), and gltA 15 (60%) genes, though msp4 was not detected. Phylogenetic analysis of 16S rRNA sequences showed clustering with ‘Candidatus Anaplasma camelii’ from Saudi Arabian dromedaries. This is the first report of ‘Ca. A. camelii’ and A. marginale in dromedary from Somalia, highlighting the need for further research on its impact on animal health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.